NY-ESTÉE-LAUDER
16.4.2014 15:20:59 CEST | Business Wire | Pressemeddelelse
The Estée Lauder Companies Inc. (NYSE:EL) today launched the Jo Malone London brand in Mainland China, at the Mitsukoshi store in Beijing. The brand expects to open two further doors in Shanghai and Beijing in 2014.
Jo Malone London was launched in 1994 and acquired by The Estée Lauder Companies, Inc. in 1999. It is widely regarded as the epitome of understated luxury when it comes to fragrance and is one of The Estée Lauder Companies’ ultra-prestige brands. Each Jo Malone London fragrance is created by the world’s Master Perfumers using only the finest ingredients and is designed to be worn alone or layered using Fragrance Combining to create a truly bespoke scent.
Today the brand is available in 34 countries worldwide following the launch in China and continues to inspire a loyal following. Jo Malone London first launched in Asia Pacific in Japan in 2008 and is one of the fastest growing Estée Lauder Companies’ brands across the region.
“We are thrilled to be launching Jo Malone London in China. We believe that the understated luxury of Jo Malone London along with the brand’s use of high quality and rare ingredients will appeal to the very discerning Chinese consumer,” said Fabrice Weber, President, Asia Pacific for the The Estée Lauder Companies. “China and our Chinese consumers continue to play a key role in the strategy of our company, and the launch of the Jo Malone London brand reinforces our commitment to this dynamic market.”
“Jo Malone London is the epitome of British luxury. We are thrilled to be opening in China, a country bursting with history, energy, and promise. The dynamic cities of Shanghai and Beijing, where we will open our highly anticipated new boutiques, perfectly reflect the innovative spirit of Jo Malone London. We are excited to introduce the World of Jo Malone London™ to such a vibrant new audience,” said Maureen Case, Global Brand President, Jo Malone London and Bobbi Brown Cosmetics.
"Another star in The Estée Lauder Companies’ portfolio, Jo Malone London was extremely well-received by consumers when it was launched in Hong Kong several years ago and since that time, we have seen an increasing number of loyal consumers from China,” said Joy Fan, General Manager of The Estée Lauder Companies in China. “As a result, we felt it was time to launch the brand to Chinese consumers. It’s the primary role of the China team to understand local consumer needs and bring the most appropriate brands to the China market.”
The Estée Lauder Companies first entered China in 1993 with two of its brands, Estée Lauder and Clinique. Jo Malone London is the Company’s 15th brand to be sold there. China remains one of The Estée Lauder Companies’ fastest growing markets as the Company continues to expand distribution in smaller cities and the portfolio of its brands.
The forward-looking statements in this press release, including those in the individuals’ remarks, involve risks and uncertainties. Factors that could cause actual results to differ materially from those forward-looking statements include competition, changes in regulation, risks of doing business abroad and the other risks described in the Company’s filings with the U.S. Securities and Exchange Commission, including the most recent quarterly report on Form 10-Q.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in over 150 countries and territories under the following brand names: Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, M•A•C, Bobbi Brown, Tommy Hilfiger, Kiton, La Mer, Donna Karan, Aveda, Jo Malone, Bumble and bumble, Darphin, Michael Kors, American Beauty, Flirt!, GoodSkin Labs, Grassroots Research Labs, Tom Ford, Coach, Ojon, Smashbox, Ermenegildo Zegna, Aerin Beauty, Osiao, Marni and Tory Burch.
Contact:
U.S. Media Relations:
Jill Marvin, +1-212-572-4438
Asia
Media Relations:
Fiona Morgan, +852 3420 5550
Jo Malone
London Media Relations:
Claire Goodwin, +44 870 034 3762
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
